Metraipolis › archive › dc_5c2bac6a2fef
The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41373685
- DOI
- 10.3390/ijms262311534
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:14:10.663Z
- SHA-256 of the archived text
d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895- Stable URL of this page
https://metraipolis.com/documento/dc_5c2bac6a2fef
How to cite
The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685 — Europe PMC (en), https://europepmc.org/article/MED/41373685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c2bac6a2fef (Metraipolis archive dc_5c2bac6a2fef, sha256 d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895)
BibTeX
@misc{dc5c2bac6a2fef,
title = {The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis — Europe PMC PMID:41373685},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41373685},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c2bac6a2fef; sha256 d4ea7c140abb466409047f9660409eee3f07cf49b8d07827e21ecb18dd20a895},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41373685. Agents can read the archived copy with the MCP tool read_document.